RETRO-URETERAL DELIVERY OF AAV-KP VECTORS FOR RENAL GENE TRANSFER AND THE ASSESSMENT OF TRANSGENE REABSORPTION IN THE KIDNEY

Monogenic disorders cause a substantial fraction of chronic kidney disease, yet no renal gene therapy exists, partly because adeno-associated virus (AAV) vectors transduce the kidney poorly after systemic delivery. Screening a barcoded library of 80 natural and chimeric AAV serotypes administered retrogradely into the mouse renal pelvis identified AAV-KP1, AAV-KP2 and AAV-KP3 as enriched in the injected kidney but not in the liver. Individual validation confirmed efficient transduction of the administered kidney, with vector genome copy numbers approaching hepatic levels, 50- to 500-fold above the contralateral kidney and far above AAV9. Using kidney-specific (KSPC) and ubiquitous (CMV) promoters, transduction was detected in collecting duct, distal convoluted tubule, proximal tubule, Bowman's capsule, interstitial cells and podocytes, with cell-type coverage depending on the promoter. Unexpectedly, GFP and mCherry protein was abundant in proximal tubules of kidneys lacking transgene mRNA, including contralateral and intravenously dosed kidneys. RNA-FISH, vector genome quantification and serum mCherry indicate that this protein derives from circulating transgene product filtered and reabsorbed by the proximal tubule rather than from local transduction. Retrograde delivery of AAV-KP capsids therefore achieves broad renal epithelial transduction, and transgene mRNA must be assessed alongside protein if kidney-tropic capsids are to be ranked reliably.

Authors

Institutions

Publication Details

Journal
bioRxiv (Cold Spring Harbor Laboratory)
Published
2026-11-18
DOI
https://doi.org/10.64898/2026.11.18.767076
Primary Topic
Virus-based gene therapy research
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

RETRO-URETERAL DELIVERY OF AAV-KP VECTORS FOR RENAL GENE TRANSFER AND THE ASSESSMENT OF TRANSGENE REABSORPTION IN THE KIDNEY

Gloria González‐Aseguinolaza, Rafael Aldabe, Míriam Méndez, Leszek Lisowski et al.
bioRxiv (Cold Spring Harbor Laboratory)
Virus-based gene therapy research
preprint

RETRO-URETERAL DELIVERY OF AAV-KP VECTORS FOR RENAL GENE TRANSFER AND THE ASSESSMENT OF TRANSGENE REABSORPTION IN THE KIDNEY

Gloria González‐Aseguinolaza, Rafael Aldabe, Míriam Méndez, Leszek Lisowski, Leire Neri, Sergio Milagros, Nerea Santana‐Gonzalez, Martin Bilbao, Nerea Zabaleta, Beatriz Carte, Africa Vales
preprint en

Abstract

Monogenic disorders cause a substantial fraction of chronic kidney disease, yet no renal gene therapy exists, partly because adeno-associated virus (AAV) vectors transduce the kidney poorly after systemic delivery. Screening a barcoded library of 80 natural and chimeric AAV serotypes administered retrogradely into the mouse renal pelvis identified AAV-KP1, AAV-KP2 and AAV-KP3 as enriched in the injected kidney but not in the liver. Individual validation confirmed efficient transduction of the administered kidney, with vector genome copy numbers approaching hepatic levels, 50- to 500-fold above the contralateral kidney and far above AAV9. Using kidney-specific (KSPC) and ubiquitous (CMV) promoters, transduction was detected in collecting duct, distal convoluted tubule, proximal tubule, Bowman's capsule, interstitial cells and podocytes, with cell-type coverage depending on the promoter. Unexpectedly, GFP and mCherry protein was abundant in proximal tubules of kidneys lacking transgene mRNA, including contralateral and intravenously dosed kidneys. RNA-FISH, vector genome quantification and serum mCherry indicate that this protein derives from circulating transgene product filtered and reabsorbed by the proximal tubule rather than from local transduction. Retrograde delivery of AAV-KP capsids therefore achieves broad renal epithelial transduction, and transgene mRNA must be assessed alongside protein if kidney-tropic capsids are to be ranked reliably.

bioRxiv (Cold Spring Harbor Laboratory)
Children's Medical Research Institute (AU), Centro de Investigación Médica Aplicada (ES), Universidad de Navarra (ES)
Virus-based gene therapy research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon